Table of Contents Europe Xerostomia (Dry Mouth) Therapeutics Market Report 2012-2023 1 Xerostomia (Dry Mouth) Therapeutics Overview 1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics 1.2 Classification of Xerostomia (Dry Mouth) Therapeutics by Product Category 1.2.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Salivary Stimulants 1.2.4 Salivary Substitutes 1.2.5 Dentifrices 1.3 Europe Xerostomia (Dry Mouth) Therapeutics Market by Application/End Users 1.3.1 Europe Xerostomia (Dry Mouth) Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 OTC 1.3.3 Prescription 1.4 Europe Xerostomia (Dry Mouth) Therapeutics Market by Region 1.4.1 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Xerostomia (Dry Mouth) Therapeutics (2012-2023) 1.5.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics 2.2 Raw Material Analysis of Xerostomia (Dry Mouth) Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Xerostomia (Dry Mouth) Therapeutics 2.4 Other Costs Analysis of Xerostomia (Dry Mouth) Therapeutics 2.5 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics 2.6 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics 2.7 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Xerostomia (Dry Mouth) Therapeutics Players/Suppliers Profiles and Sales Data 3.1 GlaxoSmithKline plc 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 GlaxoSmithKline plc Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.2 Church & Dwight Co., Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Church & Dwight Co., Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.3 Colgate-Palmolive Company 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Colgate-Palmolive Company Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.4 Hikma Pharmaceuticals PLC 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Hikma Pharmaceuticals PLC Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.5 Pendopharm 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pendopharm Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.6 Sun Pharmaceuticals Industries Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sun Pharmaceuticals Industries Ltd. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.7 Lupin Pharmaceuticals, Inc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Lupin Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.8 Pfizer, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Pfizer, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.9 Parnell Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Parnell Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.10 Acacia Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Acacia Pharma Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.11 OraCoat 4 Europe Xerostomia (Dry Mouth) Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Xerostomia (Dry Mouth) Therapeutics Market Competition by Players/Manufacturers 4.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Type 4.2.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Application 4.3.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application 5 Germany Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 5.1 Germany Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 5.1.1 Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 Germany Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 5.3 Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 6 UK Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 6.1 UK Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 6.1.1 UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 UK Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 6.3 UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 7 France Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 7.1 France Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 7.1.1 France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 France Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 7.3 France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 8 Russia Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 8.1 Russia Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 8.1.1 Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 Russia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 8.3 Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 9 Benelux Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 9.1 Benelux Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 9.1.1 Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 9.3 Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 10 Italy Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 10.1 Italy Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 10.1.1 Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 10.1.3 Italy Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 10.3 Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 11 Spain Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 11.1 Spain Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 11.1.1 Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 11.1.3 Spain Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 11.3 Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) 13.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) 13.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 Europe Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2018-2023) 13.4 Europe Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Xerostomia (Dry Mouth) Therapeutics Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Salivary Stimulants Picture Figure Salivary Substitutes Picture Figure Dentifrices Picture Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Applications in 2017 Figure OTC Picture Figure Prescription Picture Table Europe Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure France Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics Table Industry News List of Xerostomia (Dry Mouth) Therapeutics Figure Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2017 Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers Europe Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Basic Information List Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Basic Information List Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Basic Information List Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Basic Information List Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Basic Information List Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Basic Information List Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Basic Information List Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Basic Information List Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Company Acacia Pharma Basic Information List Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Players/Manufacturers Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Figure 2017 Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate by Type (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Regions in 2017 Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2017 Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Application (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure UK Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure France Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Russia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Italy Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Spain Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Type (2018-2023) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table Europe Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc Church & Dwight Co., Inc. Colgate-Palmolive Company Hikma Pharmaceuticals PLC Pendopharm Sun Pharmaceuticals Industries Ltd. Lupin Pharmaceuticals, Inc. Pfizer, Inc. Parnell Pharmaceuticals, Inc. Acacia Pharma OraCoat